Join to View Full Profile
975 Sereno DrVallejo, CA 94589
Phone+1 707-651-1077
Dr. Suga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Marie Suga is an Oncologist based in Vallejo, CA, in Hematologic Oncology specializing in Thoracic malignancies. Her medical education was completed at Tufts University School of Medicine, followed by a residency in Internal Medicine at Brown University and a fellowship in Hematology and Medical Oncology at the University of California Davis Health. She has contributed to multiple medical publications and partaken in clinical trials as a Contact and Principal Investigator, notably in lung and breast cancer studies. She was recognized with a Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2011.
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2010
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2004 - 2007
Tufts University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2007 - 2026
RI State Medical License 2005 - 2007
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy Start of enrollment: 2009 May 01
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsFinancial Hardship Among Patients With Early-Stage Colorectal Cancer.Gelareh Sadigh, Fenghai Duan, Na An, Ilana D Gareen, JoRean Sicks
JAMA Network Open. 2024-09-03 - 3 citationsMachine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.Lujia Chen, Ying Wang, Chunhui Cai, Ying Ding, Rim S Kim
Journal of Clinical Oncology. 2024-05-01 - 7 citationsPatient-Reported Financial Burden of Treatment for Colon or Rectal Cancer.Sheetal Kircher, Fenghai Duan, Na An, Ilanan F Gareen, JoRean D Sicks
JAMA Network Open. 2024-01-02
Press Mentions
Major Financial Hardship Common After Cancer Diagnosis, Despite InsuranceJanuary 4th, 2022- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Grant Support
- Kaiser Permanente NCI National Community Oncology Research Program, NCORPKAISER FOUNDATION RESEARCH INSTITUTE2014–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
